Report Scope
The current report will provide detailed exposure to the high-throughput screening (HTS) market. This report analyzes the market trends of HTS with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period is from 2024 through 2029) and regional HTS markets. This report will highlight the current and future market potential of HTS and present a detailed analysis of the competitive environment. It will also cover regulatory scenarios, drivers, restraints and opportunities. Lastly, it presents the market share for key market players.
The market scope in this report is segmented into detection method, component, technology and end user. The report covers spectroscopy, mass spectrometry, chromatography, calorimetry, X-ray diffraction and microscopy based on detection methods. These detection methods are further classified into subcategories for this report. The market is segmented based on components into instruments/
platforms, consumables (e.g., reagents, kits), services and software, and analytics (e.g., bioinformatics). The market is segmented based on technology: cell-based assays, ultra-high-throughput screening, label-free technology and lab-on-a-chip. End users are segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), research and government institutes, and lab and pathological practices.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. Data from 2023 will be provided as the base year for market estimates, with forecasts for 2024 through 2029.
The report’s goals include:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook